PSA testing shifts from routine to personalised prostate cancer decisions

Prostate cancer screening has become less about routine checks and more about personalised decisions. Major medical groups now recommend tailored approaches rather than universal PSA testing. This shift follows years of changing advice, leaving many men uncertain about when—or if—they should get tested.

A recent Super Bowl ad, backed by Novartis, tried to ease fears by framing the PSA test as just a simple blood draw. The campaign even featured NFL stars like Rob Gronkowski and George Kittle to encourage men to overcome their hesitation.

The PSA test measures prostate-specific antigen in the blood and is often the first step in screening. A result above 4 ng/mL is usually flagged as abnormal, but this isn't a definitive sign of cancer. Even benign conditions—like an enlarged prostate, prostatitis, or recent physical strain—can push levels higher.

To avoid false alarms, doctors advise against testing right after ejaculation, intense exercise, or if urinary symptoms are present. If a PSA reading is elevated, the next step isn't always a biopsy. Instead, the test is often repeated under better conditions to rule out temporary spikes.

Medical guidelines have evolved significantly over the past decade. The U.S. Preventive Services Task Force initially discouraged routine PSA screening for men without symptoms, later adjusting to recommend selective testing for those aged 55–69. Similarly, the American Cancer Society and European Association of Urology now stress shared decision-making, focusing on men at higher risk. The concern is balancing potential benefits with risks like overdiagnosis, unnecessary treatment, and anxiety.

Not all prostate cancers trigger high PSA levels, either. Some aggressive cases may appear even when numbers seem normal. This complexity means doctors now prioritise individual risk factors—age, family history, ethnicity—over one-size-fits-all screening.

The move away from universal PSA testing reflects a broader trend toward precision in healthcare. Men are now encouraged to discuss their risks and preferences with a doctor before deciding on screening. While campaigns like the Super Bowl ad aim to reduce fear, the focus remains on informed choices rather than automatic testing.